Reported by Lee Yoon-Jung, Edaily — Global medical beauty company JDBIO Co., Ltd. (CEO Kim Jin-Dong) announced on the 11th that it continues to achieve annual growth, driven primarily by its expanding presence in overseas markets.
Building on consistent performance, JDBIO continues its trajectory of global expansion. In 2024, the company recorded KRW 90.64 billion in sales, marking a 40% increase from the previous year. This follows a strong growth trend from KRW 20.7 billion in 2022 and KRW 64.8 billion in 2023, breaking its own sales record for the third consecutive year. For 2025, JDBIO is targeting over KRW 120 billion in annual revenue and $70 million in exports.
To achieve this, the company is actively reinforcing its global business structure. This includes the establishment of a Global Division, strengthening its core brands such as RICHESSE™, DEMEI™, and OneFill™, introducing new business ventures, and expanding into the Latin American market, a region identified for its high growth potential.
In particular, the company is aggressively expanding its sales operations in Latin America to increase revenue and diversify its global network.
Additionally, JDBIO plans to deepen its partnership with PharmaResearch to accelerate the growth of Rejuran cosmetics in the Chinese market, where they anticipate over 100% year-on-year growth.
CEO Kim Jin-Dong stated,
“With our strong technology and customer trust, JDBIO has achieved remarkable success in overseas markets. We expect to exceed KRW 120 billion in sales by 2025. Moving forward, we aim to further enhance our brand competitiveness and differentiate ourselves with unique product strategies and new launches to accelerate global expansion.”
Meanwhile, JDBIO is preparing to release a lineup of new competitive products tailored to global demand. The company plans to strengthen cooperation with international distribution partners and actively participate in major exhibitions and marketing campaigns to ensure successful global market entry for its upcoming products.
[Source] Kim Jin-dong, CEO of JD Bio, “We Expect KRW 120 Billion in Sales by Entering the Latin American Market in 2025”, Edaily, April 11, 2025
Click here to view the full article (in Korean).